Theophylline Capsule

Theophylline capsules leverage the synergistic mechanisms of phosphodiesterase inhibition and adenosine receptor antagonism to promote potent bronchodilation and enhanced diaphragmatic contractility in patients with chronic obstructive lung diseases. This encapsulated delivery system is specifically engineered to facilitate a controlled release profile, ensuring that therapeutic plasma concentrations are maintained within a narrow window to maximize efficacy while mitigating the risk of dose-related toxicities. By providing a stable pharmacokinetic profile, the capsule format improves clinical outcomes through superior nocturnal symptom control and simplified dosing regimens that support long-term patient compliance.